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Abstract 22 
 23 
Bovine viral diarrhea- and Border disease viruses of sheep belong to the highly 24 
diverse genus pestivirus of the Flaviviridae. Ruminant pestiviruses may infect a wide 25 
range of domestic and wild cloven-hooved mammals (artiodactyla). Due to its 26 
economic importance, programs to eradicate bovine viral diarrhea are a high priority 27 
in the cattle industry. By contrast, Border disease is not a target of eradication, 28 
although the Border disease virus is known to be capable of also infecting cattle. In 29 
this work, we compared single dose experimental inoculation of calves with Border 30 
disease virus with co-mingling of calves with sheep persistently infected with this 31 
virus. As indicated by seroconversion, infection was achieved only in one out of 32 
seven calves with a dose of Border disease virus that was previously shown to be 33 
successful in calves inoculated with BVD virus. By contrast, all calves kept together 34 
with persistently infected sheep readily became infected with Border disease virus. 35 
The ease of viral transmission from sheep to cattle and the antigenic similarity of 36 
bovine and ovine pestiviruses may become a problem for demonstrating freedom of 37 
BVD by serology in the cattle population.  38 
 39 
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Introduction 45 
 46 
Originally, the pestiviruses of ruminants  were differentiated according to the host 47 
species from which they were isolated and referred to as bovine viral diarrhea virus 48 
(BVD virus) and Border disease virus of sheep (Carlsson 1991, Carlsson and Belak 49 
1994, Campell et al. 1995, Paton et al. 1997;  for reviews, see Nettleton and 50 
Entrican, 1995; Nettleton et al., 1998; Løken 1995). More recently, nucleotide 51 
sequencing documented the wide genetic heterogeneity and taxonomic position of 52 
these viruses (Becher et al., 1997; 2003; Vilcek et al., 2005; reviewed by Becher and 53 
Thiel, 2011) and confirmed that ruminant pestiviruses may not only jump the species 54 
barrier between bovines and sheep, but also infect other ruminants, including wild 55 
species.  (reviewed by Passler and Walz, 2010). In domestic animals, the inter-56 
species infection appears to occur  particularly in the direction of cattle to sheep 57 
(Løken 1995; Carlsson and Belak 1994, Krametter-Frötscher et  al. 2008; Danuser et 58 
al., 2009). In contrast, infections of cattle with the sheep pestivirus have been noted 59 
less frequently (Becher et al., 1997; Cranwell et al. 2007; Krametter-Frötscher et  al. 60 
2008; Hornberg et al. 2009). It was shown that calves kept together with sheep 61 
seroconverted and that the antibodies were directed against Border disease virus 62 
(Krametter-Frötscher et al. 2008). Information on the clinical effects of infection with 63 
Border disease virus in cattle is scarce. By contrast, Border disease virus was shown 64 
to cause severe infections in chamois in the Spanish Pyrenees (Marco et al., 2007, 65 
2011).  In this work we compared the effects of co-mingling of calves with sheep 66 
persistently infected with Border disease virus vs. inoculation of calves with a single 67 
virus dose.  68 
 69 
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Animals, materials and methods 70 
 71 
Sheep persistently infected with Border disease virus (PI sheep) and 72 
characterization of viruses. 73 
Two female one-year-old sheep persistently infected with Border disease virus were 74 
used in this study. Sheep #1, of the white alpine breed, was initially taken to the 75 
clinic for investigation at two days of age with clinical signs typical of border disease, 76 
i.e. ataxia, tremor and hairy fleece. Sheep #2, of the black-brown alpine breed, was 77 
transferred to the clinic at three months of age with head tremor and ataxia. 78 
Interestingly, the clinical signs of infection gradually decreased in both animals and 79 
had disappeared to almost undetectable levels when the sheep were brought in 80 
contact with the calves. Both animals tested positive for pestivirus antigen by 81 
immunohistological investigation of skin biopsies as described previously (Arquint, 82 
2003; Thür et al, 1997). Over a period of one year, leucocytes, and intermittently also 83 
nasal swabs, of sheep #1 tested positive for pestiviral RNA by RT-PCR.  Leucocytes, 84 
epilated hair, urine, muzzle and nasal swabs of sheep #2 were positive for viral RNA. 85 
Both animals were negative for pestivirus antibody. Virus was repeatedly isolated 86 
from leucocytes of both animals in cultured sheep synovial membrane cells. 87 
Sequencing showed that the viruses isolated belong to the species Border disease 88 
virus of the pestivirus genus and may form a new genetic cluster (Figure 1, marked 89 
by arrow). The virus isolated from sheep # 1 was labeled CH-R4786 and that of 90 
sheep # 2 CH-R4785. After passaging twice both viruses we decided to use strain 91 
CH-R4786 for single dose inoculation because it grew to a higher titer than strain 92 
CH-R4785. Both PI sheep were also tested for ovine herpes virus type 2 (Hüssy et 93 
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al., 2001) because this virus may cause malignant catarrhal fever in cattle (reviewed 94 
by Russell et al., 2009). Both animals were found to be positive.  95 
 96 
All animal experiments were approved by the Veterinary Office of the Canton of 97 
Zurich.  98 
 99 
Pestiviral status of the calves before initiation of the experiments. 100 
The two experiments consisted of a quarantine period followed by the infection 101 
phase. For logistic reasons, the quarantine was set at 17 days for the orally 102 
inoculated calves and at 30 days for the calves exposed to PI sheep. Before 103 
purchase and at the end of the quarantine period all animals tested negative for 104 
pestivirus antigen and antibodies in blood samples and for pestivirus antigen in skin 105 
biopsies (Thür et al., 1997).  106 
 107 
Inoculation of calves with Border disease virus and co-mingling of calves with 108 
PI sheep. 109 
Seven calves (4 male/3 female) were orally inoculated with Border disease virus 110 
(see below). The animals were of various breeds (Simmental, Holstein Friesian, 111 
Charolais x Braunvieh, Charolais x Holstein Friesian) and were between 87 and 176 112 
days old at the beginning of the quarantine period (145.9 [32.65] (mean [SD]).  The 113 
protocol and virus dose for oral inoculation were the same as previously used for 114 
experimental infection of calves with BVD virus (Hilbe et al., 2007). Each animal 115 
received a total of 4.8ml of Border disease virus BD4 isolated from PI sheep #1, 116 
dispensed in the oropharyngeal cavity by four strokes using a Foxy Plus™ hand 117 
sprayer (Birchmeier Corporation,  Stetten, Switzerland, www.birchmeier.com). The 118 
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total dose per animal of 7x105 TCID50 was verified by backtitration. In the co-mingling 119 
experiment, nine male calves of of various breeds (Braunvieh, Simmental, Holstein 120 
Friesian) that were between 99 and 156 days old (131 [18.8] (131 + 18.8 days) were 121 
kept together with sheep # 1 and # 2 for 72 days.  122 
 123 
Clinical investigations and laboratory tests 124 
To avoid contamination strict quarantine rules were observed throughout the 125 
experiments, involving separation of the animal groups, changing clothes and 126 
disinfection between attending different groups of animals.  127 
The animals were subjected to standardized clinical investigation by two of the 128 
authors (CR: oral inoculation, SR: co-mingling of calves and PI sheep). The 129 
investigations included recording of body temperature, heart beat and respiratory 130 
frequencies, lung and digestive tract auscultation, inspection for signs of diarrhea, 131 
nasal and ocular discharge and inspection of mucosae. In the oral inoculation 132 
experiment, clinical investigations were done on days -9, -6, -3, thereafter daily until 133 
day 21, followed by days 25, 28, 32, and 35. Nasal swabs were collected daily on the 134 
first 21 days post-infection. Blood samples for virus detection and hematological 135 
investigations followed the same schedule as the clinical investigation but continued 136 
until the termination of the experiment on day 70. The schedule of antibody 137 
determination is seen in Figure 3A and B. Hematological investigations included 138 
erythrocyte and differential leucocyte counts, hemoglobin, packed cell volume, mean 139 
corpuscular hemoglobin concentration, mean corpuscular hemoglobin, and mean 140 
corpuscular volume. In the co-mingling experiment, the calves were subjected to 141 
standardized clinical investigation at the beginning and end of the quarantine period. 142 
The schedule of clinical and laboratory investigations was as follows: hematology: 143 
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days 0, 3,6,7,8,9,10,11,12,13,14, days 16 through 72: every second day. BVD virus 144 
and – serology: 0,2,4,6, thereafter daily until day 20, followed by every second day 145 
until the termination of the experiment; nasal swabs: up to day 41 for all calves as for 146 
virus and serology, thereafter every second day for calves # 2,5,6, and continued 147 
until day 72 for calves # 5 and # 6. 148 
  149 
Detection of pestiviral RNA 150 
Quantitative (q) RT-PCR was used to detect viral RNA in the EDTA blood and in the 151 
nasal swab medium. RNA was extracted from 150μl of anti-coagulated whole blood 152 
using the BioRobot Universal System and the QIAamp virus BioRobot MDx Kit 153 
(Qiagen, CH-8694 Hombrechtikon, Switzerland). Viral RNA was quantitated using 154 
the Qiagen Cador BVDV RT-PCR kit. Volumes were chosen to give a final dilution 155 
factor of 12.5. The test recognizes a genome sequence conserved in pestiviruses 156 
and can therefore also be used for the detection of border disease virus (Stalder et 157 
al., 2008). Following the evaluation of the raw data the amount of the viral DNA 158 
present in the sample was expressed in CT values, whereby CT values of >45 were 159 
considered to be negative and those with a CT value of 30-45 were considered to be 160 
weakly positive. The RNA isolations and RT-PCR preparations were done in 161 
separate laboratories. The testing for viral RNA in the nasal swab medium was done 162 
analogously to the method described for the viral RNA testing in the blood. 163 
 164 
Sequencing 165 
A genome fragment of 504 nucleotides spanning from the 5‘ untranslated region to 166 
the core protein including the Npro was amplified as described previously (Bachofen 167 
et al., 2008) and the DNA fragments of the correct length were sequenced by 168 
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Microsynth GmbH (CH-9436 Balgach). The sequence data were analysed by means 169 
of the SeqMan (DNASTAR Inc., Madison, USA) and the Clone Manager (Scientific & 170 
Educational Software, Cary, USA) softwares. The sequences are deposited in 171 
Genbank  (CH-R4785: GU244490; CH-R4786: GU244489)  172 
 173 
Serological investigations 174 
 175 
ELISA 176 
A biphasic in-house ELISA was used for antibody screening as previously described 177 
(Rüfenacht et al., 2000). The antigen of this ELISA contains a high concentration of 178 
the conserved immunogenic NS3 protein and only little of the more strain-specific E2 179 
protein  (Wageck Canal et al., 1998).  ELISA microtiter plates (Maxisorp, A/S Nunc, 180 
Kamstrub, Denmark) were coated with antigen derived from bovine turbinate cells 181 
infected with the cytopathic BVD viral strain R1935/72 (Oregon C24V, subgenotype 182 
1a). A horse radish peroxidase labelled goat anti-bovine IgG antibody (light and 183 
heavy chain, Kirkegaard and Perry Labs., Gaithersburg, USA) was used to detect 184 
bound antibody. To visualize bound labelled antibody, the substrate ABTS (2,2'-185 
azino-di-(3-ethyl benzthiazoline-6- sulphonic acid), Roche Diagnostics) was added 186 
and color measured in an ELISA reader at 405nm. 187 
 188 
Serum neutralization test 189 
To confirm the specificity of the antibodies we carried out serum neutralization 190 
assays using Border disease virus CH-R4786 and BVD virus CH-04-01b. The latter 191 
is a BVD-1h virus strain, which is the most frequent subgenogroup found in the 192 
Swiss cattle population (Bachofen et al., 2008). 193 
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 194 
Procedure at the onset of erosive changes at the muzzle and the muzzle cavity 195 
Specimens were taken at the onset of erosive changes at the muzzle and the muzzle 196 
cavity and investigated for the presence of Border disease virus. 197 
 198 
Statistics 199 
The data were collected and evaluated by means of the StatView 5.1 programme 200 
(SAS Institute, CHJ-8602 Wangen). The data were descriptively analysed (mean 201 
values, standard deviations, frequency distributions). A generalized linear model was 202 
also used to check for possible significant changes in the variables during the course 203 
of the investigations (programme Stata statistical software, Stata Corp., 2009; 204 
Release 101.; College Station, TX, USA: StataCorp LP). P-values of < 0.05 were 205 
considered to be significant. 206 
 207 
208 
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Results 209 
 210 
Clinical findings 211 
Four out of the seven orally inoculated calves had a reduced appetite on day 2 post-212 
infection whereas this was observed in three out of nine calves on day six after the 213 
introduction of PI sheep. Transient increases >39.5°C in body temperature were 214 
noted in individual animals of the two groups both during the quarantine and the 215 
infection periods. These changes occurred scattered over time. All calves exposed to 216 
PI sheep showed erosions of the muzzle mucosa between days 3 and 17, whereas 217 
this was the case with four out of seven orally inoculated animals (animal #1: days 218 
17-22 and days 29/30; animal #2: days 24-30; animal #5: days 4-29; animal #6: days 219 
5-22; animal #7: days 7-15). The erosions were located in the areas of the rostral 220 
palate (see Fig. 2A, orally inoculated calf), the gingival area of the incisors and the 221 
mucosa of the upper and lower lips (Fig. 3B, calf exposed to PI sheep). The lesions 222 
showed a roundish or oblong slightly reddened area and were associated with a loss 223 
of integrity of the surface epithelium. The animals often salivated and the edges of 224 
the gingiva were inflamed.  225 
 226 
Serology 227 
Serum samples obtained at various time points were tested for antibodies using 228 
ELISA. In addition, serum samples obtained at the termination of the experiment 229 
were assayed by SNT. Sera of all orally inoculated animals remained close (0±2%) 230 
to the zero value of positive control until day 28 post-infection and thereafter the sera 231 
of individual animals varied between -8% and +9% (Fig 3A). Of the serum samples 232 
obtained on day 70 post oral inoculation, only the sample of animal #6 showed a 233 
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neutralizing antibody titer of 422 to Border disease virus CH-R4786, whereas the 234 
samples of all other animals were negative (<8). The samples of animals exposed to 235 
PI sheep remained negative until day 22. Thereafter, with the exception of calf #4, 236 
we noted an increase in the ELISA antibody titers. At the termination of the 237 
experiment, six out of nine animals were in the ELISA positive range and three 238 
(calves #4, 5 and 6) were in the negative range (Fig 3B). To determine the pestiviral 239 
specificity of the antibodies, we compared the SNT titers against Border disease 240 
virus CH-R4786 and a BVD 1h virus. Using CH-R4786 as the challenge virus, the 241 
titers ranged from 450 in the serum of calf #4 to 3,500 in calf #2. These titers were 242 
10-30 times higher than those directed against BVD virus as the challenge, which 243 
indicated that the antibodies were indeed directed against Border disease virus 244 
(Figure 3C).  245 
 246 
Hematology 247 
 During the entire experiment, i.e. during quarantine and infection period, none of the 248 
calves showed leukopenia or significant changes in the parameters of red blood cells 249 
(erythrocyte number, PCV, hemoglobin concentration, MCH, MCHC, MCV).  250 
 251 
Virological investigations 252 
Viral RNA was not detected in any of the nasal swabs and blood samples taken from 253 
the calves exposed to PI sheep, and the same was true for the orally inoculated 254 
calves.  255 
 256 
 257 
 258 
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Discussion 259 
 260 
BVD and Border disease viruses may be viewed as “partial generalists”, infecting not 261 
only cattle and sheep, but also a wide array of wildlife species including deer, 262 
antelopes, camelids and wildebeest (reviewed in Passler and Walz, 2010). The 263 
spread of Border disease virus to cattle is likely to gain in importance because 264 
existing BVD eradication programs are run without concomitant efforts to control 265 
Border disease (Krametter-Frötscher et al., 2010). Therefore, the focus of this work 266 
was on the transmission of Border disease virus from sheep to cattle.  267 
In a herd of susceptible bovines exposed to sheep PI with Border disease virus, the 268 
time point of transmission of virus may differ between individual animals. 269 
Consequently, seroconversion as well as possible clinical signs of infection with 270 
Border disease virus may occur scattered over time. To control for this, we 271 
compared single dose experimental inoculation with contact exposure to PI sheep. 272 
The oral route for inoculation of the calves with Border disease virus and dose of 273 
infection were chosen to allow a direct comparison with a previous experiment in 274 
which we used BVD virus. As indicated by seroconversion in only one out of seven 275 
calves orally inoculated with Border disease virus vs. 6/6 calves inoculated with BVD 276 
virus (Hilbe et al., 2007), Border disease virus was less efficient than BVD virus at 277 
infecting cattle. The relative inefficiency of Border disease virus correlates with a 278 
poor growth of this virus in cultured bovine turbinate cells (unpublished observation). 279 
The virus concentrations of the strain of Border disease virus shed by the PI sheep 280 
are unknown, but PI sheep readily transmitted Border disease virus to calves kept in 281 
the same herd. Interestingly, viral RNA was not detected in blood and nasal swabs in 282 
any of the calves. This contrasts with the previous experiment in which we detected 283 
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BVD virus by isolation in cell culture in a majority of the orally inoculated animals 284 
(Hilbe et al., 2007). In our hands, real-time RT-PCR is more sensitive than cell 285 
culture isolation. Thus, viremia of Border disease virus may be of short duration and 286 
low titer in calves. Different from the previous experimental infection with BVD virus 287 
(Hilbe et al., 2007), we did not observe fever or changes in the leucocyte numbers in 288 
calves that seroconverted to Border disease virus. The same was true also for 289 
acutely infected sheep and goats (unpublished observation), which points to a low 290 
virulence also in these host species. In agreement with earlier reports, the PI sheep 291 
showed neurological signs of Border disease only in the first weeks of their lives 292 
(Løken, 1998; Krametter-Frötscher et al., 2010).  293 
  294 
The skin lesions observed in some of the calves in both experiments deserve 295 
comment. In contrast to the mucosal disease-like lesions reported in sheep 296 
chronically or persistently infected with Border disease virus (Monies et al., 2004; 297 
Hilbe et al., 2009), the lesions observed in the calves were mild and transient. 298 
Moreover, the lesions were also much less severe than those in acute BVD recently 299 
described by Hessman et al. (2012). For several reasons, we are at a loss to explain 300 
the cause of these lesions. Firstly, we failed to isolate pestivirus, or to demonstrate 301 
pestiviral RNA, in any of the lesions analysed. Secondly, such lesions occurred also 302 
in some orally inoculated calves that did not seroconvert to Border disease virus, as 303 
assayed by ELISA and SNT. Due to their typical clinical picture, epidemiology and 304 
absence from Switzerland we can exclude a range of agents known to cause skin 305 
lesions, such as vesicular stomatitis and parapox viruses. All evidence obtained in 306 
our and in previous experiments (Torleiv  Løken, personal communication) do not 307 
support the view that the lesions were directly caused by Border disease virus. Thus, 308 
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additional experiments will be required to determine the cause of these lesions, 309 
among them contact experiments between sheep uninfected by Border disease virus 310 
and calves originating from the same herds.  311 
 312 
Bovines persistently infected with border disease virus have only rarely been 313 
observed in the field (Cranwell et al., 2007; Krametter-Frötscher et al., 2008; Strong 314 
et al., 2010). Although contact between bovines and sheep is not uncommon under 315 
the prevailing management conditions, we detected only 13 bovines PI with Border 316 
disease virus among 7,573 analyzed by sequencing in the course of the Swiss BVD 317 
eradication campaign (Bachofen and Stalder, in preparation). The ease of 318 
transmission of Border disease from PI sheep to seronegative cattle contrasts with 319 
the rarity of bovines found PI with Border disease virus in the field. In addition to a 320 
possible difference in the degree of adaptation to sheep vs. cattle as host species, a 321 
strong herd immunity to BVD virus may decrease the risk of persistent infection with 322 
Border disease virus in cattle. In crossed neutralization assays we previously 323 
observed up to tenfold antibody titer differences between representative strains of 324 
different BVD-1 virus subgroups (Bachofen et al., 2008) and this study shows up to 325 
30-fold antibody titer differences between the homologous Border disease strain and 326 
a representative of the most frequent subgroup of BVD virus 1 found in our cattle 327 
population (see Figure 3C). Vaccination against BVD virus was very rare before, and 328 
has been banned since, the start of the eradication program. This suggests that 329 
natural infection of cattle with BVD virus may confer some degree of immunity also to 330 
Border disease virus. Before the start of BVD eradication, some 60% of the cattle 331 
population was seropositive to BVD virus (Rüfenacht et al., 2000), as compared to 332 
some 20% of the sheep seropositive to Border disease virus (Schaller et al., 2000; 333 
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Danuser et al., 2007) . However, as the eradication program progresses, herd 334 
immunity to BVD virus decreases and more bovines will become susceptible for 335 
Border disease virus. While the biological consequences for a seronegative cattle 336 
population are difficult to judge at this time, infections with Border disease clearly 337 
pose a diagnostic problem for BVD eradication. Specifically, demonstration of 338 
freedom from BVD is based on absence of antibodies to BVD in the cattle 339 
population. To our knowledge, there exists no simple test that clearly differentiates, 340 
on the species level, antibodies to BVD virus from antibodies to Border disease 341 
virus. As indicated above and shown in the literature, both BVD- and Border disease 342 
viruses are antigenically highly diverse, with the antibodies to individual virus strains 343 
cross-reactive to varying degrees (Nettleton et al., 2008; Becher et al., 2003; 344 
Bachofen et al. 2008; Ridpath et al., 2010; Strong et al., 2010). The SNT clearly 345 
shows the difference in titer between antibodies to the Border disease virus strain 346 
used in our experiment and a representative strain of the most prevalent BVD virus 347 
subgroup present in the cattle population (Fig. 3C). However, due to its high 348 
resolution between antibodies to different subgroups of BVD virus (Bachofen et al., 349 
2008), an SNT using just one strain of BVD-1 virus is not representative for the entire 350 
species. Moreover, the SNT is unsuitable for mass testing of sera because it is work-351 
intensive and depends on cultured cells. The development of a simple test that 352 
allows a clear-cut and efficient differentiation of antibodies to BVD- and Border 353 
disease viruses is a high priority in BVD eradication. The ELISA used in our study is 354 
clearly less sensitive for detecting antibodies to Border disease virus than the SNT 355 
(compare Figs 3B and 3C). This  ELISA detects mainly antibodies to the 356 
nonstructural protein NS3 of a BVD-1 virus (Wageck-Canal et al., 1998). Although 357 
significantly more conserved than E2, the main target protein of neutralizing 358 
15 
 
antibodies, the derived amino acid sequences of the NS3 of BVD- and Border 359 
disease viruses are different between, and heterogeneous within, the two species of 360 
pestivirus (Stalder, unpublished). Crossed ELISAs of immune sera to the different 361 
subgroups of these two virus species would show if NS3 is a suitable antigen for 362 
differentiation.  363 
 364 
From the practical viewpoint of BVD eradication programs, it seems advisable to 365 
minimize contact between sheep and cattle because of the complications due to 366 
spillover of Border disease virus from sheep. This would also reduce the risk of 367 
malignant catarrhal fever in bovines, a fatal disease which is caused by ovine herpes 368 
virus-2, a virus carried virtually by all sheep (for a review, see Russell et al., 2009).   369 
 370 
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Figure captions 380 
 381 
Figure 1.  Phylogenetic analysis of selected pestiviruses based on Npro.   382 
The tree was constructed from the complete Npro coding sequences except for the 383 
two strains Aydinb/04 (EU930014) and Burdur (EU930014) (Shortening all 384 
sequences to 420 nucleotides did not change the structure of the tree). Sequences 385 
were obtained from Genbank and analyzed as described (Peterhans et al., 2010).  386 
Please note that the taxonomic position of some of the atypical pestiviruses and of 387 
some Border disease viruses is open, e.g. the HoBi like, Chamois and Turkey 388 
viruses. The position of the Border disease viruses used in this work is indicated by 389 
an arrow. Genbank accession #: CH-R4785: GU244490 (Npro), JQ994199 (5’UTR);  390 
CH-R4786: GU244489 (Npro), JQ994200(5’UTR).  391 
 392 
Figure 2.  Lesions.  393 
A: erosion in the rostral palate of orally inoculated calf #7, B: erosions in calf #3 394 
exposed to PI sheep.  395 
 396 
Figure 3.  Antibody response in calves. 397 
A: Antibody response of orally inoculated calves; B: calves exposed to sheep 398 
persistently infected with Border disease; C: comparison of neutralizing antibody titer 399 
to Border disease virus CH-R4786 strain and BVD virus strain CH-04-01b of 400 
subgenogroup 1h. 401 
402 
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